Accès ouvert
2025
article
OpenAlex
Chiara Giubbi, Marianna Martinelli, Michelle Rizza, Maria Letizia Di Meo et autres
This study investigated the detection of high-risk Human Papillomavirus (hrHPV) and seven other pathogens associated with sexually transmitted infections (STIs) in matched clinician-collected cervical samples and self-taken vaginal and urine specimens collected from 342 asymptomatic women referred to colposcopy to evaluate (i) …
it
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Chiara Giubbi, Marianna Martinelli, Michelle Rizza, Maria Letizia Di Meo et autres
High-risk Human Papillomavirus (hrHPV) persistent infection is acknowledged as the primary cause of cervical cancer. Coinfection with other sexually transmitted infections (STIs) may be associated with a higher risk of cervical lesion progression. This study investigated the detection of hrHPV and 7 …
Accès ouvert
2024
preprint
OpenAlex
Chiara Giubbi, Chiara Villa, Maria Letizia Di Meo, Illari Sechi et autres
HPV51 belongs to group I high-risk HPV (hrHPV) genotypes with a high prevalence of infection in numerous epidemiological studies, although its occurrence varies across geographical regions. To better understand the presence of variants and genetic variation of HPV51, this study aimed to …
it
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Chiara Giubbi, Marianna Martinelli, Maria Letizia Di Meo, Ruth Chinyere Njoku et autres
The introduction of Human Papillomavirus (HPV) testing in cervical cancer screening enhanced the opportunity to introduce self-collection as an innovative approach to improve coverage rates. Validation and standardization of the pre-analytical and analytical procedures are crucial for the quality assurance of HPV …
it
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Marianna Martinelli, Chiara Giubbi, Maria Letizia Di Meo, Federica Perdoni et autres
In the context of cervical cancer prevention, where human papillomavirus (HPV) infection is pivotal, HPV testing is replacing Pap Smear in primary screening. This transition offers an opportunity for integrating self-sampling to enhance coverage. We evaluated the accuracy of HPV testing using …
it
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Christhardt Köhler, David Cibula, Martina Romanová, Martina Borčinová et autres
de, cz, it, nl, at, es, be, pl, ch, no, hu
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Massimo Origoni, Francesco Cantatore, Francesco Sopracordevole, Nicolò Clemente et autres
Quality Control (QC) and Quality Assurance (QA) principles are essential for effective cervical cancer prevention. Being a crucial diagnostic step, colposcopy's sensitivity and specificity improvements are strongly advocated worldwide since inter- and intra-observer differences are the main limiting factors. The objective of …
it, ch
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Diletta Fumagalli, Tommaso Grassi, Luca Bazzurini, Tommaso Bianchi et autres
it
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Francesco Fanfani, Luigi Pedone Anchora, Giampaolo Di Martino, Nicolò Bizzarri et autres
it
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Giampaolo Di Martino, Andrea Alberto Lissoni, Débora Ferrari, Maria Letizia Di Meo et autres
BACKGROUND/AIM: The role of neoadjuvant chemotherapy (NACT) is under investigation in locally advanced cervical cancer (LACC). PATIENTS AND METHODS: A total of 49 patients with FIGO stage IB1-IIB cervical cancer who underwent two different regimens of weekly dose-dense NACT were included. The …
it
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Francesco Fanfani, Giorgia Monterossi, Maria Letizia Di Meo, Eleonora La Fera et autres
it
(code pays fourni par la source)